#

Los Angeles Office

dshahmirzai@focusonlegal.com
213 277-7088 ext. 1

Practice Areas

IP Licensing
Intellectual Property
Mergers & Acquisitions
Privacy & Cybersecurity
Startup & Venture Capital
Technology Transactions

Industries

Cleantech
Digital Technology
Artificial Intelligence
Digital Health
Life Sciences
Software

Education and Bar Admission

UC Davis School of Law, JD
Harvard University, School of Public Health, MS, Public Health and Epidemiology
UC Berkeley, BA in Molecular and Cell Biology, Neurobiology

Admitted to Practice in California

Dorisa Shahmirzai Hanrahan - Rated by Super Lawyers

Dorisa Shahmirzai Hanrahan, Esq.
Managing Attorney and Founder

Dorisa leads the Technology Transactions practice. She focuses her practice on technology-based transactions, including intellectual property acquisitions and licensing strategies for life sciences and technology companies including artificial intelligence and digital platforms.

As a general counsel for a multi-brand international cosmetic distribution company, Mazal Group Inc., she managed day-to-day legal matters, handling, enforcing and prosecuting over 100 IP assets spanning 25 counties. She is recognized expert in new media law, intellectual property exploitation, social media law, copyrights and trademark protection and related legal and business affairs. Using her expertise in intellectual property law, and contract negotiation she advises clients in deal making, development, and marketing, on web, mobile and social platforms.

Dorisa’s representative transactions include: development, collaboration, license and material transfer agreements for a broad range of life science technologies including gene therapy, genomics, proteomics and bioinformatics technologies; software, telecommunications and IT agreements, including technology development, licensing and marketing agreements; clinical trial agreements; and supply, distribution, sales representative and other supply-side agreements for biopharmaceuticals, diagnostic, medical device, telecommunications and software products. She handles investment agreements and IPO deals for technology companies. She also manages IP portfolios for companies internationally and domestically.

She worked at Clifford Chance in Barcelona Spain handling several large pharmaceutical patent deals and litigations. After law school she clerked with San Francisco Superior Court. She spent her first summer clerking for an Italian firm Trevisan & Cuonzo Avvocati in Milan, Italy.

Publication: Leslie Howard Hoffenberg and Dorisa Shahmirzai Hanrahan, Four Fair Factors, Los Angeles Lawyer Magazine, February 2016.

Professional Activities: Panel Attorney California Lawyers for the Arts, Adjunct Faculty at UCLA Extension

Public Service: Board member of Boys and Girls Club Burbank Chapter (2014-present), Served as Grassroots Public Servant at Peruvian Amazon Rain Forest Conservation

Speaker: Copyright Basics, Fair Use and Music Piracy at the CLA, September 2009, and December 2013. Copyrights and Fair Use at Women in Film, Spring 2012, Spring 2014.

She has been selected as a rising star in Super Lawyer Magazine for 2015, 2016 and 2017.

#

Los Angeles Office

213 277-7088

Practice Areas

Patent Preparation and Prosecution
IP Due Diligence
IP Licensing
Intellectual Property Litigation
Mergers & Acquisitions
Startup & Venture Capital
Technology Transactions

Industries

Pharmaceutical
Biotechnology
Medical Devices
Diagnostics
Digital Health
Life Sciences

Education and Bar Admission

George Mason University School of Law, JD
The George Washington University Medical Center, PhD in Pharmacology
Duke University, BS in Neuroscience

Admitted to Practice in Maryland and Washington D.C.
Registered U.S. Patent Attorney before the U.S. Patent and Trademark Office

John Weatherspoon, Esq.
U.S. Patent Attorney

John is a U.S. patent attorney with nearly twenty years of experience representing clients in a wide range of industries. He focuses his practice on intellectual property strategies for clients, including strategies for building and protecting patent portfolios, and monetizing clients’ valuable patent portfolios. He also has a Ph.D. in the pharmaceutical sciences and extensive experience advising clients in the pharmaceutical and biotechnology industries, other life sciences and healthcare-related industries, high tech industries, and clients in a wide range of other industries.

As outside patent counsel for numerous pharmaceutical and biotechnology companies, including Immunophotonics, he has managed the international and U.S. patent portfolio and worked with the company management to develop long-term strategies for monetizing their intellectual property assets. He has also been extensively involved in IP due diligence on behalf of clients. He is an expert in rendering patent-related legal opinions, including patentability, freedom to operate, infringement, validity and invalidity opinions, technology transfer issues, and strategic issues involving the acquisition, development, and protection of their intellectual property. He also has extensive experience with Hatch-Waxman matters, including analysis of Orange Book listed patents in the United States. In addition, he advises clients on the preparation, negotiation and handling of license agreements, enforcing their intellectual property rights, and long-term strategies for the commercialization of their technologies.

John’s representative transactions include: collaboration and material transfer agreements for a wide range of life science technologies including, for example, small molecules, plasmid-based therapeutics, biologics, and medical device technologies; competitive landscape analysis for pharmaceutical, biotechnology and diagnostics companies, and for companies in the semiconductor, computer, aerospace, electronics, petrochemical, and nanotechnology industries; and providing a broad range of intellectual property due diligence services for clients.

He worked at Winston Strawn and Morgan Lewis in Washington, D.C., handling several large pharmaceutical and biotechnology clients and litigations, and he has also taught intellectual property courses at Johns Hopkins University Carey Business School. He has also been an invited speaker for Marcus Evans, the Licensing Executives Society and an invited Mentor at the NIH Commercialization Accelerator Program (NIH CAP) FeedForward™ Sessions, sponsored by the Larta Institute.

Publication: He is the author of “A Wave of High-Profile Court Cases Has Major Impact on the BioPharmaceutical Industry” (published in the Pharmaceutical Compliance Monitor), 2015.

Professional Activities: Advisor at VesaliuX, a cross-border venture capital-backed accelerator affiliated with the venture capital investment firm Vesalius Ventures (http://www.vesaliusventures.com/). He is also a Visiting Professor at the School of Law at the Beijing Institute of Technology (B.I.T.).

Public Service: Providing pro bono service and guidance to several early-stage startup companies at the Maryland Technology Incubation Center and at the Inventors' Network of the Capital Area, in the Washington D.C. area (2009 - present).

Speaker: "Latest Trends and Developments in IP Licensing Agreements Explored! LIVE Webcast" (Knowledge Congress Live Webcast Series), 2015. He was also a speaker on Intellectual Property Licensing, at the 2012 INPEX Annual Conference, Pennsylvania, June 2012. In addition, he was a speaker on the topic of "IP Research Strategies: Getting a Grip on the Competitive Landscape and Identifying the Best Targets" Annual Licensing Executive Society Conference, San Diego, October, 2011.